Correspondence
Body-mass index and metastatic melanoma outcomes

https://doi.org/10.1016/S1470-2045(18)30239-0Get rights and content

References (5)

There are more references available in the full text version of this article.

Cited by (3)

  • A large scale meta analysis identifies common adverse events with checkpoint inhibitors vs chemotherapy in melanoma patients

    2019, International Immunopharmacology
    Citation Excerpt :

    The data collected by the Surveillance Epidemiology and End Results from the National Cancer Institute indicated that the incidence of malignant melanoma is steadily increasing among white people, as reflected by a 60% increase in the last 3 decades [3]. Therefore, malignant melanoma has become one of the major public health issues and an important topic in cancer research [4]. There are many therapeutic approaches for melanoma.

These authors contributed equally.

View full text